{"slug":"daewoong-pharmaceutical","name":"대웅제약","name_en":"Daewoong Pharmaceutical","ticker":"069620.KS","updated_at":"2026-07-11T10:21:49.92+00:00","canonical":"https://valuechain.wiki/daewoong-pharmaceutical","kicker":"코스피 대형주","kicker_en":"KOSPI large cap","lead":"보툴리눔 톡신 나보타와 위장약 등을 보유한 국내 대형 제약사다. 코스피 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A major Korean pharmaceutical company known for the botulinum toxin Nabota and gastrointestinal drugs. KOSPI large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"전문의약품(ETC)"},{"name":"일반의약품·나보타"}],"total":"약 1.4조원 (FY2024)"},"segments_en":{"parts":[{"name":"Prescription drugs (ETC)"},{"name":"OTC and Nabota"}],"total":"~₩1.4T (FY2024)"},"returns_yearly":{"2021":-13.5,"2022":17.5,"2023":-27.5,"2024":25,"2025":23.1,"2026":-21.9},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}